EVOK

$0.00

(

+0.00%

)
Quote details

stock

Evoke Pharma Inc

NASDAQ | EVOK

10.69

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$16.61M

Market Cap

-

P/E Ratio

-1.25

EPS

$10.79

52 Week High

$1.94

52 Week Low

HEALTHCARE

Sector

EVOK Chart

Recent Chart
Price Action

EVOK Technicals

Tags:

EVOK Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $9.9M
Total Revenue $10M
Cost Of Revenue $357K
Costof Goods And Services Sold $357K
Operating Income -$5.2M
Selling General And Administrative $15M
Research And Development $16K
Operating Expenses $15M
Investment Income Net -
Net Interest Income -$148K
Interest Income $353K
Interest Expense $501K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.2M
Income Before Tax -$5.4M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.4M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$4.9M
Net Income -$5.4M

Revenue & Profitability

Earnings Performance

EVOK Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $18M
Total Current Assets $17M
Cash And Cash Equivalents At Carrying Value $14M
Cash And Short Term Investments $14M
Inventory $445K
Current Net Receivables $2.4M
Total Non Current Assets $281K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $14T
Other Current Assets $776K
Other Non Current Assets -
Total Liabilities $10M
Total Current Liabilities $10M
Current Accounts Payable $2.3M
Deferred Revenue -
Current Debt -
Short Term Debt $5.1M
Total Non Current Liabilities $101K
Capital Lease Obligations $160K
Long Term Debt -
Current Long Term Debt $5M
Long Term Debt Noncurrent -
Short Long Term Debt Total $5.2M
Other Current Liabilities $3M
Other Non Current Liabilities -
Total Shareholder Equity $7M
Treasury Stock -
Retained Earnings -$129M
Common Stock $149
Common Stock Shares Outstanding $1.9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$5.5M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory $33K
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$191
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.4M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $9.9M
Total Revenue $10M
Cost Of Revenue $357K
Costof Goods And Services Sold $357K
Operating Income -$5.2M
Selling General And Administrative $15M
Research And Development $16K
Operating Expenses $15M
Investment Income Net -
Net Interest Income -$148K
Interest Income $353K
Interest Expense $501K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.2M
Income Before Tax -$5.4M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.4M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$4.9M
Net Income -$5.4M

EVOK News

EVOK Profile

Evoke Pharma Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Evoke Pharma, Inc. is a specialty pharmaceutical company based in Solana Beach, California, focused on addressing unmet medical needs in gastroenterological diseases. The company’s flagship product, Gimoti, represents a novel nasal formulation of metoclopramide designed to effectively treat gastroparesis in diabetic patients, highlighting Evoke's commitment to innovative therapeutic solutions. With a strategic emphasis on expanding its portfolio in the gastrointestinal sector, Evoke is poised for growth and aims to enhance patient outcomes through its targeted drug development initiatives. Given the increasing demand for specialized treatments, Evoke’s unique position in the market reflects potential for significant impact and returns in the specialty pharmaceutical landscape.

CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
YDKG
-5.55%
$0.05
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.18%
$2.68
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
CPNG
-5.94%
$30.22
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
YDKG
-5.55%
$0.05
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.18%
$2.68
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
CPNG
-5.94%
$30.22
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.